Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Anesthesiology Reports
Erschienen in: Current Anesthesiology Reports 2/2020

31.03.2020 | Neuromuscular Blockade (GS Murphy, Section Editor)

Incidence and Risk Factors for Postoperative Residual Neuromuscular Blockade

verfasst von: Roy Soto

Erschienen in: Current Anesthesiology Reports | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To define the incidence of residual neuromuscular blockade (rNMB) and identify patients at risk.

Recent Findings

Incidence of rNMB continues to be high, and risk factors are complex and difficult to predict. Sequelae of rNMB, however, are significant.

Summary

Despite literature describing the significance of rNMB on patient safety, the incidence continues to be high, and risk factors are difficult to predict. Patient, anesthetic, and surgical risk factors all contribute, and an understanding of the unique risks for each individual patient is required to properly prevent rNMB.
Literatur
1.
Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS. Residual paralysis at the time of tracheal extubation. Anesth Analg. 2005;100:1840–5.CrossRef
2.
Maybauer DM, Geldner G, Blobner M, Pühringer F, Hofmockel R, Rex C, et al. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia. 2007;62:12–7.CrossRef
3.
Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–8.CrossRef
4.
Yu B, Ouyang B, Ge S, Luo Y, Li J, Ni D, et al. Incidence of postoperative residual neuromuscular blockade after general anesthesia: a prospective, multicenter, anesthetist-blind, observational study. Curr Med Res Opin. 2016;32:1–9.CrossRef
5.
Brueckmann B, Sasaki N, Grobara P, Li MK, Woo T, de Bie J, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth. 2015;115:743–51.CrossRef
6.
Vested M, Tarpgaard M, Eriksen K, Rasmussen LS. Incidence of residual neuromuscular blockade in children below 3 years after a single bolus of cisatracurium 0.1 mg/kg: a quality assurance study. Acta Anaesthesiol Scand. 2020;64:168–72.CrossRef
7.
Domenech G, Kampel MA, García Guzzo ME, Novas DS, Terrasa SA, Fornari GG. Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study. BMC Anesthesiol. 2019;19:143.CrossRef
8.
•• Grabitz SD, Rajaratnam N, Chhagani K, Thevathasan T, Teja BJ, Deng H, et al. The effects of postoperative residual neuromuscular blockade on hospital costs and intensive care unit admission: a population-based cohort study. Anesth Analg. 2019;128:1129–36 While clinicians tend to focus on patient safety and quality of care, they must also contend with system-based issues when introducing new technologies or new medications. As a result, pharmacoeconomic discussions must frequently be had with pharmacy and administrative personnel. This study nicely describes the correlation of rNMB with increased health system cost, particularly as related to ICU admission.CrossRef
9.
•• Saager L, Maiese EM, Bash LD, Meyer TA, Minkowitz H, Groudine S, et al. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: the prospective, observational, multicenter RECITE-US study. J Clin Anesth. 2019;55:33–41 This study (along with the Canadian and Chinese counterpart studies) neatly summarizes the risk factors for rNMB in a prospective fashion, and describes the continued high incidence, despite good clinical care and seemingly appropriate reversal with neostigmine.CrossRef
10.
Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120–8.CrossRef
11.
Murphy GS, Szokol JW, Franklin M, Marymont JH, Avram MJ, Vender JS. Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesth Analg. 2004;98:193–200.CrossRef
12.
Pühringer FK, Heier T, Dodgson M, Erkola O, Goonetilleke P, Hofmockel R, et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced neuromuscular block in adult and elderly patients. Acta Anaesthesiol Scand. 2002;46:364–71.CrossRef
13.
Leykin Y, Pellis T, Lucca M, Lomangino G, Marzano B, Gullo A. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg. 2004;99:1086–9.CrossRef
14.
Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol. 2010;27:874–81.CrossRef
15.
Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology. 2012;117:964–72.CrossRef
16.
Lee S, Ro YJ, Koh WU, Nishiyama T, Yang HS. The neuromuscular effects of rocuronium under sevoflurane-remifentanil or propofol-remifentanil anesthesia: a randomized clinical comparative study in an Asian population. BMC Anesthesiol. 2016;16:65.CrossRef
17.
Arain SR, Kern S, Ficke DJ, Ebert TJ. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand. 2005;49:312–5.CrossRef
18.
Maidatsi PG, Zaralidou AT, Gorgias NK, Amaniti EN, Karakoulas KA, Giala MM. Rocuronium duration of action under sevoflurane, desflurane or propofol anaesthesia. Eur J Anaesthesiol. 2004;21:781–6.CrossRef
19.
Dahaba AA, Perelman SI, Moskowitz DM, Bennett HL, Shander A, Xiao Z, et al. Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology. 2006;104:950–3.CrossRef
20.
Fortier LP, McKeen D, Turner K, de Médicis É, Warriner B, Jones PM, et al. The RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121:366–72.CrossRef
21.
Kocaturk O, Kaan N, Kayacan N, Ertugrul F. The incidence of postoperative residual curarization following the use of intermediate-acting muscle relaxants and related factors. Middle East J Anaesthesiol. 2014;22:583–90.PubMed
22.
Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Vender JS, et al. Residual neuromuscular block in the elderly: incidence and clinical implications. Anesthesiology. 2015;123:1322–36.CrossRef
23.
• Rudolph MI, Ng PY, Deng H, Scheffenbichler FT, Grabitz SD, Wanderer JP, et al. Comparison of a novel clinical score to estimate the risk of residual neuromuscular block prediction score and the last train-of-four count documented in the electronic anaesthesia record: a retrospective cohort study of electronic data on file. Eur J Anaesthesiol. 2018;35:883–92 Retrospective electronic data reviews allow for larger analyses of patient variables and can discover associations that would otherwise be missed in prospective trials. Although this was relatively small in scope, it represents an important first step in using “big data” to detect risks for rNMB.PubMed
24.
Christensson E, Ebberyd A, Hårdemark Cedborg A, Lodenius Å, Österlund Modalen Å, Franklin KA, et al. Hypoxic ventilatory response after rocuronium-induced partial neuromuscular blockade in men with obstructive sleep apnoea. Anaesthesia. 2019. https://​doi.​org/​10.​1111/​anae.​14806.
25.
Capron F, Fortier LP, Racine S, Donati F. Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography. Anesth Analg. 2006;102:1578–84.CrossRef
Metadaten
Titel
Incidence and Risk Factors for Postoperative Residual Neuromuscular Blockade
verfasst von
Roy Soto
Publikationsdatum
31.03.2020
Verlag
Springer US
Erschienen in
Current Anesthesiology Reports / Ausgabe 2/2020
Elektronische ISSN: 2167-6275
DOI
https://doi.org/10.1007/s40140-020-00386-6

Weitere Artikel der Ausgabe 2/2020

Current Anesthesiology Reports 2/2020 Zur Ausgabe

Neuromuscular Blockade (GS Murphy, Section Editor)

Deep Neuromuscular Blockade: Does the Data Support Its Use in Surgical Patients?

Neuromuscular Blockade (GS Murphy, Section Editor)

Evaluation of the Efficacy and Safety of Neostigmine in Reversing Neuromuscular Blockade

Anesthesia for Trauma (TE Grissom, Section Editor)

Regional Anesthesia in the Burn Trauma Patient

Blood Management (KA Tanaka, Section Editor)

Patient Blood Management in Adult Extracorporeal Membrane Oxygenation Patients

Blood Management (KA Tanaka, Section Editor)

Preoperative Anemia Management: What’s New in 2020?

Regional Anesthesia (P Kukreja, Section Editor)

Local Anesthetic Systemic Toxicity (LAST) – a Review and Update

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren